Navigation Links
Cambridge Semantics to Present on Smart Data and Competitive Intelligence Informatics at 2013 Pharma CI Conference & Exposition
Date:8/22/2013

BOSTON (PRWEB) August 22, 2013

Cambridge Semantics, leading provider of smart data solutions for the pharmaceutical industry, today announced its participation in the 2013 Pharma CI Conference & Exposition. Lee Feigenbaum, Vice President of Marketing and Technology for Cambridge Semantics, will present on pharma competitive intelligence (CI) solutions to automate data gathering, investigation and analytics to conference delegates. In addition, Cambridge Semantics is exhibiting at the conference.

When:
September 18, 2013
9:00 a.m. – 9:35 a.m.

Where:
Pharma CI Conference & Exhibition
Hilton East Brunswick Hotel
3 Tower Center Blvd.
East Brunswick, New Jersey 08816

Details: Large pharmaceutical organizations, like companies in many industries, face challenges with enterprise data management and end user data consumption. At Pharma CI Conference & Exposition, Feigenbaum’s presentation will introduce the concept of “CI Informatics,” technology solutions dedicated to gathering and distributing high-quality competitive intelligence information. Feigenbaum’s presentation will provide examples of CI Informatics in use based on Cambridge Semantics’ award-winning Anzo Pharma Competitive Intelligence solution.

Using semantic technology, Anzo proactively gathers and routes relevant and targeted CI information to the right people at the right time, from the right information sources – whether internal or external to the company, structured or unstructured. The software can be used for intelligence gathering across a number of use cases, including compound licensing, biopartnering, market intelligence, comparative effectiveness research, drug repositioning, self-service competitive intelligence reporting and analytics, and more.

Cambridge Semantics’ Anzo platform has been deployed by R&D CI teams, business development and sourcing teams, marketing groups and knowledge management teams at a number of leading pharma companies, including Merck, Lilly, Novartis, Biogen and others.

Media and analysts interested in a briefing with Cambridge Semantics, please contact Lora Friedrichsen at Cambridge(at)globalresultspr(dot)com or +1 949 608 0276.

About Cambridge Semantics

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics or Facebook.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11051384.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioMed Realty Acquires 320 Charles In Cambridge, MA
2. Cambridge Semantics to Highlight Innovations in Drug Safety and Business Development at DIA 2013
3. Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill
4. Cambridge Semantics Wins SIIA Software CODiE Award for Best Business Intelligence and Analytics Solution
5. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
6. Cambridge Semantics to Present the Case for Unified Information Access at Enterprise Data World 2013
7. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
8. Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
9. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
10. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
11. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... ... June 22, 2017 , ... Charm Sciences, Inc. is pleased to announce that ... to be appropriate as a screening test at dairies and farms for raw commingled ... and the Charm EZ Lite system. These systems are a combination incubator and reader ...
(Date:6/20/2017)... ... ... Biologist Dawn Maslar MS has found a biomarker that she claims verifies ... The Neuroscience of Meeting, Dating, Losing Your Mind, and Finding True Love, Maslar found ... step, in my estimation, was to scientifically track the evidence of commitment in men,” ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., ... to announce the issuance of a new patent covering ... hyperuricemia by the U.S. Patent and Trademark Office on ... winner of the Buzz of Bio award in 2014 ... akin to developing non-drug approaches to chronic disease. Renadyl™, ...
(Date:6/20/2017)... Parsippany, NJ (PRWEB) , ... June 20, 2017 , ... ... OHAUS makes the transition from being a trusted supplier in the weighing industry, to ... including cell extractions, ELISA essays, enzyme reactions, immunoassays, hybridizations and more, allowing for ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):